ArriVent BioPharma
AVBP · NASDAQ
$18.85+$0.91 (+5.07%)TodayMarket closed ·
Prev close $17.94
Who owns AVBP
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 62.8% of AVBP’s shares.
- Montanova Capital, LLC9.7%
- INFINITUM ASSET MANAGEMENT, LLC9.5%
- HHLR Advisors, Ltd.8.4%
- OrbiMed Advisors, LLC6.5%
- Next 6 largest institutions28.6%
- All other shareholders37.2%
| Holder | Shares | % of shares |
|---|---|---|
| Montanova Capital, LLC | 4.52M | 9.70% |
| INFINITUM ASSET MANAGEMENT, LLC | 4.44M | 9.53% |
| HHLR Advisors, Ltd. | 3.93M | 8.44% |
| OrbiMed Advisors, LLC | 3.03M | 6.50% |
| BlackRock Institutional Trust Company, N.A. | 2.91M | 6.26% |
| Fidelity Management & Research Company LLC | 2.78M | 5.97% |
| HBM Partners AG | 2.20M | 4.71% |
| Octagon Capital Advisors LP | 1.97M | 4.23% |
| Vanguard Capital Management, LLC | 1.77M | 3.81% |
| Sofinnova Investments, Inc | 1.70M | 3.64% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| Fidelity Select Biotechnology Portfolio | 1.35M | 2.90% |
| Vanguard Total Stock Market Index Fund | 1.34M | 2.87% |
| iShares Russell 2000 ETF | 980.51K | 2.11% |
| State Street SPDR S&P Biotech ETF | 925.64K | 1.99% |
| Fidelity Small Cap Index Fund | 411.62K | 0.88% |
Insider trades
Form 4 filings by officers, directors and large holders
Insiders made no open-market buys or sales of AVBP in the last 6 months.
| Insider | Type | Shares | Value |
|---|---|---|---|
| Parsey Merdad | Award | 13.56K | — |
| Nolet Chris | Award | 13.56K | — |
| Hohneker John | Award | 13.56K | — |
| Peterson Kristine | Award | 13.56K | — |
Short interest
Settled Sep 30, 2026
- Shares short
- 8.45M
- Days to cover
- 11.25
- % of shares outstanding
- 18.15%
- Average daily volume
- 751.30K
- Change since last report
- −3.6%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.